Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96SN8
UPID:
CK5P2_HUMAN
Alternative names:
CDK5 activator-binding protein C48; Centrosome-associated protein 215
Alternative UPACC:
Q96SN8; Q5JV18; Q7Z3L4; Q7Z3U1; Q7Z7I6; Q9BSW0; Q9H6J6; Q9HCD9; Q9NV90; Q9UIW9
Background:
CDK5 regulatory subunit-associated protein 2, also known as CDK5 activator-binding protein C48 and Centrosome-associated protein 215, plays a crucial role in cell cycle regulation. It acts as a potential regulator of CDK5 activity through its interaction with CDK5R1 and is a negative regulator of centriole disengagement. This protein is involved in mitotic spindle orientation, spindle checkpoint activation, and microtubule dynamics, contributing to centrosomal maturation and neurogenesis.
Therapeutic significance:
Given its involvement in Microcephaly 3, primary, autosomal recessive, a condition characterized by significantly reduced brain size and mental retardation, understanding the role of CDK5 regulatory subunit-associated protein 2 could open doors to potential therapeutic strategies.